|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/18/2024 |
$24.19 |
$24.78 |
$24.05 |
$24.31 |
1.71M | 04/19/2024 |
$24.14 |
$24.94 |
$23.64 |
$23.90 |
4.54M | 04/22/2024 |
$24.27 |
$24.27 |
$23.20 |
$24.10 |
2.43M | 04/23/2024 |
$24.04 |
$25.47 |
$23.44 |
$23.47 |
1.40M | 04/24/2024 |
$23.56 |
$23.85 |
$22.63 |
$22.74 |
1.11M |
|
Beam Therapeutics is a biotechnology company. Co. has identified four development candidates to date: three from its ex vivo platform, with two candidates targeting hemoglobinopathies and one candidate targeting T-cell leukemia, and one from its in vivo platform targeting glycogen storage disease. BEAM-102 directly corrects the causative mutation in sickle cell disease by recreating a naturally-occurring normal human hemoglobin variant, HbG-Makassar. BEAM-201 is an anti-CD7, multiplex edited, allogeneic chimeric antigen receptor T cell development candidate for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. | |
|
Beam Therapeutics (BEAM) has the following price history information. Looking back at BEAM historical stock prices for the last five trading days, on April 18, 2024, BEAM opened at $24.19, traded as high as $24.78 and as low as $24.05, and closed at $24.31. Trading volume was a total of 1.71M shares. On April 19, 2024, BEAM opened at $24.14, traded as high as $24.94 and as low as $23.64, and closed at $23.90. Trading volume was a total of 4.54M shares. On April 22, 2024, BEAM opened at $24.27, traded as high as $24.27 and as low as $23.20, and closed at $24.10. Trading volume was a total of 2.43M shares. On April 23, 2024, BEAM opened at $24.04, traded as high as $25.47 and as low as $23.44, and closed at $23.47. Trading volume was a total of 1.40M shares. On April 24, 2024, BEAM opened at $23.56, traded as high as $23.85 and as low as $22.63, and closed at $22.74. Trading volume was a total of 1.11M shares.
BEAM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Beam Therapeutics shares, starting with a $10,000 purchase of BEAM, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/06/2020 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$18.75 |
|
End price/share: |
$22.74 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
21.28% |
|
Average Annual Total Return: |
4.69% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$12,130.38 |
|
Years: |
4.21 |
|
|
|
Date |
Close |
04/18/2024 | $24.31 | 04/19/2024 | $23.90 | 04/22/2024 | $24.10 | 04/23/2024 | $23.47 | 04/24/2024 | $22.74 |
|
|